Literature DB >> 32040338

Stress Allostasis in Substance Use Disorders: Promise, Progress, and Emerging Priorities in Clinical Research.

Gaylen E Fronk1, Sarah J Sant'Ana1, Jesse T Kaye2,3, John J Curtin1.   

Abstract

Clinicians and researchers alike have long believed that stressors play a pivotal etiologic role in risk, maintenance, and/or relapse of alcohol and other substance use disorders (SUDs). Numerous seminal and contemporary theories on SUD etiology posit that stressors may motivate drug use and that individuals who use drugs chronically may display altered responses to stressors. We use foundational basic stress biology research as a lens through which to evaluate critically the available evidence to support these key stress-SUD theses in humans. Additionally, we examine the field's success to date in targeting stressors and stress allostasis in treatments for SUDs. We conclude with our recommendations for how best to advance our understanding of the relationship between stressors and drug use, and we discuss clinical implications for treatment development.

Entities:  

Keywords:  addiction; allostasis; stress; substance use disorders; treatment

Year:  2020        PMID: 32040338      PMCID: PMC7259491          DOI: 10.1146/annurev-clinpsy-102419-125016

Source DB:  PubMed          Journal:  Annu Rev Clin Psychol        ISSN: 1548-5943            Impact factor:   18.561


  135 in total

1.  Alcohol and tobacco use and heart rate reactivity to a psychosocial stressor in an adolescent population.

Authors:  Brittany E Evans; Kirstin Greaves-Lord; Anja S Euser; Joke H M Tulen; Ingmar H A Franken; Anja C Huizink
Journal:  Drug Alcohol Depend       Date:  2012-06-21       Impact factor: 4.492

2.  Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat.

Authors:  Serena Stopponi; Lorenzo Somaini; Andrea Cippitelli; Giordano de Guglielmo; Marsida Kallupi; Nazzareno Cannella; Gilberto Gerra; Maurizio Massi; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2011-09-02       Impact factor: 4.530

3.  The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects.

Authors:  Melanie L Schwandt; Carlos R Cortes; Laura E Kwako; David T George; Reza Momenan; Rajita Sinha; Dimitri E Grigoriadis; Emilio Merlo Pich; Lorenzo Leggio; Markus Heilig
Journal:  Neuropsychopharmacology       Date:  2016-04-25       Impact factor: 7.853

4.  Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder.

Authors:  Kenzie L Preston; William J Kowalczyk; Karran A Phillips; Michelle L Jobes; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein
Journal:  Psychopharmacology (Berl)       Date:  2018-07-07       Impact factor: 4.530

Review 5.  Stress- and allostasis-induced brain plasticity.

Authors:  Bruce S McEwen; Peter J Gianaros
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

6.  Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder.

Authors:  Boadie W Dunlop; Elisabeth B Binder; Dan Iosifescu; Sanjay J Mathew; Thomas C Neylan; Julius C Pape; Tania Carrillo-Roa; Charles Green; Becky Kinkead; Dimitri Grigoriadis; Barbara O Rothbaum; Charles B Nemeroff; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2017-07-04       Impact factor: 13.382

7.  Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry.

Authors:  Suzanne C Segerstrom; Gregory E Miller
Journal:  Psychol Bull       Date:  2004-07       Impact factor: 17.737

8.  Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.

Authors:  Molly Magill; Lara A Ray
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

9.  Neuroendocrine and cardiovascular reactions to acute psychological stress are attenuated in smokers.

Authors:  Annie T Ginty; Alexander Jones; Douglas Carroll; Tessa J Roseboom; Anna C Phillips; Rebecca Painter; Susanne R de Rooij
Journal:  Psychoneuroendocrinology       Date:  2014-06-16       Impact factor: 4.905

10.  Alcohol's effects on emotionally motivated attention, defensive reactivity and subjective anxiety during uncertain threats.

Authors:  Daniel E Bradford; Courtney A Motschman; Mark J Starr; John J Curtin
Journal:  Soc Cogn Affect Neurosci       Date:  2017-11-01       Impact factor: 3.436

View more
  5 in total

1.  Stressor-elicited smoking and craving during a smoking cessation attempt.

Authors:  Megan E Schultz; Gaylen E Fronk; Natalie Jaume; Katherine P Magruder; John J Curtin
Journal:  J Psychopathol Clin Sci       Date:  2021-12-09

2.  Prospective Prediction of Lapses in Opioid Use Disorder: Protocol for a Personal Sensing Study.

Authors:  Hannah Moshontz; Alejandra J Colmenares; Gaylen E Fronk; Sarah J Sant'Ana; Kendra Wyant; Susan E Wanta; Adam Maus; David H Gustafson; Dhavan Shah; John J Curtin
Journal:  JMIR Res Protoc       Date:  2021-12-07

3.  The Kynurenine Pathway and Mediating Role of Stress in Addictive Disorders: A Focus on Alcohol Use Disorder and Internet Gaming Disorder.

Authors:  Joon Hwan Jang; So Young Yoo; Yae Eun Park; Mi-Jung Ji; Hyun-Mee Park; Ji Hyun Back; Ji Yoon Lee; Dai Jin Kim; Ji Eun Lee; Jung-Seok Choi
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

4.  Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use.

Authors:  Leigh V Panlilio; Samuel W Stull; Jeremiah W Bertz; Albert J Burgess-Hull; Stephanie T Lanza; Brenda L Curtis; Karran A Phillips; David H Epstein; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2021-02-08       Impact factor: 4.415

5.  Stressors experienced during the COVID-19 pandemic and substance use among US college students.

Authors:  Hans Oh; Adam M Leventhal; Christina C Tam; Ravi Rajkumar; Sasha Zhou; John D Clapp
Journal:  Drug Alcohol Depend Rep       Date:  2021-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.